Implantable and bio-compatible Na-O2 battery

The rechargeable nonaqueous lithium-air (Li-O(2)) battery is receiving a great deal of interest because, theoretically, its specific energy far exceeds the best that can be achieved with lithium-ion cells. Operation of the rechargeable Li-O(2) battery depends critically on repeated and highly reversible formation/decomposition of lithium peroxide (Li(2)O(2)) at the cathode upon cycling. Here, we show that this process is possible with the use of a dimethyl sulfoxide electrolyte and a porous gold electrode (95% capacity retention from cycles 1 to 100), whereas previously only partial Li(2)O(2) formation/decomposition and limited cycling could occur. Furthermore, we present data indicating that the kinetics of Li(2)O(2) oxidation on charge is approximately 10 times faster than on carbon electrodes.

Rechargeable aprotic alkali metal (Li or Na)-O2 batteries are the subject of great interest because of their high theoretical specific energy. However, the growth of dendrites and cracks at the Li or Na anode, as well as their corrosive oxidation lead to poor cycling stability and safety issues. Understanding the mechanism and improving Li/Na-ion plating and stripping electrochemistry are therefore essential to realizing their technological potential. Here, we report how the use of a Li-Na alloy anode and an electrolyte additive realizes an aprotic bimetal Li-Na alloy-O2 battery with improved cycling stability. Electrochemical investigations show that stripping and plating of Li and Na and the robust and flexible passivation film formed in situ (by 1,3-dioxolane additive reacting with the Li-Na alloy) suppress dendrite and buffer alloy anode volume expansion and thus prevent cracking, avoiding electrolyte consumption and ensuring high electron transport efficiency and continued electrochemical reactions.

Magnesium silicide nanoparticles can scavenge oxygen in the acidic tumour microenvironment and starve tumours by blocking oxygen and nutrient supply, offering a new avenue for cancer-starvation therapy.